CEL and chronic myelogenous leukemia, BCR-ABL1 positive: After adjusting for confounders, AGEs scores, and serum CML, CEL, and MG‐H1 concentrations exhibited a positive linear trend with CKM syndrome stage changes over the three‐year period (2019–2022), suggesting that higher serum AGEs scores are associated with more severe CKM syndrome stage transitions (Figure S5).